Search Results

You are looking at 91 - 100 of 561 items for :

  • Refine by Access: All x
Clear All
Full access

HSR23-089: Patient Reported Quality of Life (QoL) Among Adults Admitted for Oncology Care in Abu Dhabi, United Arab Emirates (UAE)

Derek Dale Ang Bayquen and Aaron Thrush

global score of 42 (33, 58). Patients functioned lowest in role and social domains and highest in cognitive. The most problematic symptoms were pain and fatigue, and least problematic were diarrhea and financial difficulties. The 40–49 and 50–59 age group

Full access

CLO22-074: Patient-Reported Outcomes (PROs) in Patients (pts) With Advanced Non-Small Cell Lung Cancer (aNSCLC) With Programmed Cell Death-Ligand 1 (PD-L1) ≥50% Receiving Cemiplimab (CEMI) Monotherapy Versus Platinum-Doublet Chemotherapy (CHEMO): A Focus on the EMPOWER-Lung 1 Brain Metastases Subpopulation

Mustafa Özgüroğlu, Ahmet Sezer, Saadettin Kilickap, Mahmut Gümüş, Igor Bondarenko, Miranda Gogishvili, Xuanyao He, Jennifer McGinniss, Giuseppe Gullo, Petra Rietschel, and Ruben GW Quek

statistically significant favorable difference in overall change from baseline in role functioning (8.59; 95% CI, 0.16, 17.01; p=0.0459), emotional functioning (7.27; 95% CI, 1.86, 12.69; p=0.0095), and symptoms of fatigue (-8.19; 95% CI, -15.40, -0.98; p=0

Full access

HSR20-087: Prevalence and Correlates of Psychological Distress in Patients Enrolling on Phase I Clinical Trials Using the NCCN Distress Thermometer and Problem List

Alexandra Hunt, Elizabeth Handorf, Vipin Khare, Matthew Blau, Yana Chertock, Carolyn Fang, Michael J. Hall, and Rishi Jain

evaluate the frequency of specific stressors including: practical (e.g. insurance/financial), family (e.g. family health issues), emotional (e.g. nervousness), or physical (e.g. fatigue). Adverse events on trial including hospitalizations, toxicities, or

Full access

QIM24-181: Joining Forces to Minimize Hypomagnesemia in Patients Receiving Cisplatin and Cetuximab Infusions

Janice DallaCosta, Patrick Skeffington, and Ny Tran

complete. Unfortunately, the symptoms of hypomagnesemia mimic the side effects that patients experience when on these treatments; nausea, vomiting, poor appetite, weakness, fatigue, muscle cramps and confusion. This can lead to misdiagnosis and treatment

Full access

CLO23-068: Effectiveness and Toxicity of Cetuximab With Concurrent Radiotherapy in Locally Advanced Cutaneous Squamous Cell Skin Cancer: A Case Series

Mark Joshua Chang, Wolfram Samlowski, Douglas Fife, Mac Machan, and Raul Meoz

tolerated, with 68.4% patients experienced only mild acneiform skin rash or fatigue (Grade 1 or 2). Radiotherapy produced expected side effects (skin erythema, moist desquamation, mucositis). One patient was hospitalized briefly for dehydration. Discussion

Full access

HSR20-110: The Promotion of Exercise Oncology as a Standard Part of Clinical Practice

Karen Wonders, Rob Wise, and Danielle Ondreka

strength, quality of life, depression, fear fatigue, and pain all improved following the exercise intervention. Conclusion: Exercise is an effective means to manage treatment-related symptoms in cancer and should be a part of the standard of care.

Full access

HSR20-107: Health-Related Quality of Life and Treatment Satisfaction in Chronic Lymphocytic Leukemia (CLL) Patients on Ibrutinib Compared to a Reference Group on Other CLL Treatments in a Real-World US Cross-Sectional Study

Murali Sundaram, Kathleen L. Deering, Dolly Sharma, Qing Harshaw, Jeremiah Trudeau, and Jacqueline C. Barrientos

. Respondents completed demographic/clinical information and surveys via phone (Functional Assessment of Cancer Therapy-General [FACT-G], FACT-Leukemia, and Functional Assessment of Chronic Illness Therapy [FACIT]-Fatigue and Cancer Therapy Satisfaction

Full access

QIM23-130: Committing to Resiliency: Transforming Burnout to Resilience at a National Cancer Institute (NCI) Comprehensive Cancer Center

Amy Gallagher and Amy Case

Background: Oncology providers caring for ill and dying patients are at high risk for burnout, compassion fatigue, and moral distress. Emphasized by the COVID-19 pandemic, workload stress, frontline fears, fluctuating procedures, isolation

Full access

QIM20-126: Prehabilitation Model of Care for the Patient with Breast Cancer

Karen Hock and Cari Utendorf

fibrosis and fatigue. Results: The data will demonstrate an increase in percentage of pre-operative assessments since the implementation of this program in January 2018. In addition, the data will demonstrate the increased opportunity to treat subclinical

Full access

HSR24-139: Patient-Reported Outcome Measures Used in Patients With Chronic Phase–Chronic Myeloid Leukemia: A Systematic Review of the Literature

Kathryn E. Flynn, Lovneet Saini, Aditi Kataria, Kejal Jadhav, Daisy Yang, and David Wei

health or QoL were reported in 50% of studies, whereas symptom-specific scores (eg, fatigue and gastrointestinal symptoms) were reported in 26% of studies. Longitudinal changes were reported in 11 studies; 4 studies reported direct comparisons of